Collaboration - October 8, 2026
Aiforia collaborates with PathAI
Aiforia has announced a commercial agreement with PathAI, a member of the Roche Group.
Financing - October 1, 2026
Omnio raises EUR 2.9 million for chronic wound therapy
Umeå-based biotech Omnio has raised EUR 2.9 million in an oversubscribed round from existing investors and shareholders. The funding will move the company's plasminogen-based therapy for hard-to-heal chronic wounds closer to clinical trials, with patient studies planned for 2027.
MedTech Business - September 16, 2026
Mölnlycke to split into two standalone companies
The company is to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company, provisionally named 'Mölnlycke Surgical', while Wound Care and Antiseptics continue as Mölnlycke.
Collaboration - September 14, 2026
RaySearch and Accuray expand collaboration on online adaptive radiotherapy
RaySearch Laboratories and US-based Accuray have entered a definitive agreement to expand their collaboration on online adaptive radiation therapy, with Accuray committing to purchase RayStation software licences worth USD 8 million.
MedTech Business - September 9, 2026
Glycorex signs Brazilian distribution deal
Glycorex Transplantation has agreed a distribution deal with Grupo VIDA for its Glycosorb ABO technology in Brazil, as part of the Swedish medtech company's continued market expansion.
MedTech Business - September 7, 2026
Neola Medical wins FDA Breakthrough Device Designation
Neola Medical has been granted Breakthrough Device Designation by the US FDA for Neola, its non-invasive lung monitor for preterm babies, designed to give early warning of life-threatening lung collapse.
